Since the canonical role of DNA methylation at gene promoters is gene silencing and we observed a slightly higher percentage of hypermethylated sites in these promoter regions, it is possible that gene silencing in circulating CD8+ T cells of MS patients may be present. The gene discussed is CD8A; the disease is myeloid sarcoma.